FLNA — Filana Therapeutics Share News
0.000.00%
Last trade - 00:00Cassava Sciences shares plummet as Alzheimer's drug fails in late-stage study
U.S. STOCKS ON THE MOVE-AMC, Alnylam, Super Micro
U.S. STOCKS ON THE MOVE-Replimune, Snowflake, Virpax Pharmaceuticals
Cassava Sciences shares drop as Alzheimer's drug fails in late-stage study
Cassava's Alzheimer's drug fails in late-stage study (updated)
Primary Endpoints
Cassava's Alzheimer's drug fails in late-stage study
Brief: Cassava Sciences Appoints Freda Nassif As Chief Commercial Officer
Cassava Sciences Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: Cassava Sciences Q3 Basic EPS USD -0.58
Cassava Sciences Inc expected to post a loss of 88 cents a share - Earnings Preview
Cassava gains after SEC settlement on Alzheimer's drug trial claims
Brief: Cassava Sciences Made Decision To Enter Settlement With SEC
U.S. STOCKS ON THE MOVE-IonQ, Cassava Sciences, MeridianLink
U.S. STOCKS ON THE MOVE-Regeneron, HP Inc, Honeywell International
U.S. STOCKS ON THE MOVE-Cassava Sciences, Wave Life Sciences, Bumble
U.S. STOCKS ON THE MOVE-Bumble, Cassava Sciences, IonQ
Cassava Sciences falls after SEC charges co for misleading Alzheimer's drug trial claims
Press Digest: Wall Street Journal - Sept 27